Compare QNCX & SPEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | QNCX | SPEG |
|---|---|---|
| Founded | 2012 | 2024 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 167.0M | 155.6M |
| IPO Year | 2019 | N/A |
| Metric | QNCX | SPEG |
|---|---|---|
| Price | $0.10 | $10.15 |
| Analyst Decision | Hold | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $10.00 | N/A |
| AVG Volume (30 Days) | ★ 33.4M | 21.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.09 | $9.95 |
| 52 Week High | $4.55 | $11.03 |
| Indicator | QNCX | SPEG |
|---|---|---|
| Relative Strength Index (RSI) | 27.86 | 69.08 |
| Support Level | $0.09 | $10.11 |
| Resistance Level | $0.98 | $10.35 |
| Average True Range (ATR) | 0.01 | 0.00 |
| MACD | 0.09 | -0.00 |
| Stochastic Oscillator | 18.57 | 100.00 |
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.
Silver Pegasus Acquisition Corp is a blank check company.